Clinical trial
A Phase II Study Of Troxatyl In Patients With CML Blastic Phase Disease
NCT00012259 is registered in ClinicalTrials.gov with Shire as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Study Of Troxatyl In Patients With CML Blastic Phase Disease
- Lead sponsor
- Shire
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 11, 2000
- Completion date
- March 27, 2002
- Enrollment
- 31 (actual)
- Sites
- 20
Conditions
As the registry lists them; a condition with its own page is linked.